Human host defense peptide LL-37 prevents bacterial biofilm formation

Infection and Immunity

Volumn 76, Issue 9, 2008, Pages 4176-4182

  Overhage, Joerg ^a   Campisano, Andrea ^b   Bains, Manjeet ^a   Torfs, Ellen C W ^a   Rehm, Bernd H A ^b   Hancock, Robert E W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MASSEY UNIVERSITY   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BACTENECIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; POLYMYXIN B;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BIOFILM; CELL MOTILITY; DNA MICROARRAY; DOWN REGULATION; EMBRYO; FOLLOW UP; HOST RESISTANCE; HUMAN; HUMAN CELL; IN VITRO STUDY; INNATE IMMUNITY; MICROARRAY ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; QUORUM SENSING; SEQUENCE HOMOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL ADHESION; BIOFILMS; GENE EXPRESSION PROFILING; HUMANS; LOCOMOTION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMYXIN B; PSEUDOMONAS AERUGINOSA; QUORUM SENSING;

EID: 51949104801     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00318-08     Document Type: Article

References (56)

1. Andersen, J. H., H. Jenssen, and T. J. Gutteberg. 2003. Lactoferrin and lactoferricin inhibit herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir. Antiviral Res. 58:209-215.
2. Bals, R., X. Wang, M. Zasloff, and J. M. Wilson. 1998. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc. Natl. Acad. Sci. USA 95:9541-9546.
3. Bjarnsholt, T., P. Ostrup Jensen, T. B. Rasmussen, L. Christopherson, H. Calum, M. Hentzer, H. P. Hougen, J. Rygaard, C. Moser, L. Eberl, N. Hoiby, and M. Givskov. 2005. Garlic blocks quorum sensing and promotes rapid clearing of pulmonary Pseudomonas aeruginosa infections. Microbiology 151: 3873-3880.
4. Bowdish, D. M. E., D. J. Davidson, M. G. Scott, and R. E. W. Hancock. 2005. Immunomodulatory activities of small host defense peptides. Antimicrob. Agents Chemother. 49:1727-1732.
5. Bowdish, D. M. E., D. J. Davidson, Y. E. Lau, K. Lee, M. G. Scott, and R. E. W. Hancock. 2005. Impact of LL-37 on anti-infective immunity. J. Leukoc. Biol. 77:451-459.
6. Britigan, B. E., M. B. Hayek, B. N. Doebbeling, and R. B. Fick, Jr. 1993. Transferrin and lactoferrin undergo proteolytic cleavage in the Pseudomonas aeruginosa-infected lungs of patients with cystic fibrosis. Infect. Immun. 61:5049-5055.
7. Brogden, K. A., V. C. Kalfa, M. R. Ackermann, D. E. Palmquist, P. B. McCray, Jr., and B. F. Tack. The ovine cathelicidin SMAP29 kills ovine respiratory pathogens in vitro an in an ovine model of pulmonary infection. Antimicrob. Agents Chemother. 45:331-334.
8. Brown, K. L., and R. E. W. Hancock. 2006. Cationic host defense (antimicrobial) peptides. Curr. Opin. Immunol. 18:24-30.
9. Chromek, M., Z. Slamova, P. Bergman, L. Kovacs, L. Podracka, I. Ehren, T. Hoekfelt, G. H. Gudmundsson, R. L. Gallo, B. Agerberth, and A. Brauner. 2006. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat. Med. 12:636-641.
10. Ceri, H., M. E. Olsen, C. Stremick, R. R. Read, D. Morck, and A. Buret. 1999. The Calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J. Clin. Microbiol. 37:1771-1776.
11. Costerton, J. W., P. S. Stewart, and E. P. Greenberg. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322.
12. Drenkard, E., and F. M. Ausubel. 2002. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation. Nature 416:740-743.
13. Dieter, R. S. 2004. Coronary artery stent infection. Catheter Cardiovasc. Interv. 62:281.
14. Donlan, R. M., and J. W. Costerton. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15:167-193.
15. Friedman, L., and R. Kolter. 2004. Genes involved in matrix formation in Pseudomonas aeruginosa PA14 biofilms. Mol. Microbiol. 51:675-690.
16. Hancock, R. E. W., and D. P. Speert. 2000. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment. Drug 3:247-255.
17. Hart, C. A., and C. Winstaney. 2002. Persistent and aggressive bacteria in the lungs of cystic fibrosis children. Br. Med. Bull. 61:81-96.
18. Hilpert, K., R. Volkmer-Engert, T. Walter, and R. E. Hancock. 2005. High-throughput generation of small antibacterial peptides with improved activity. Nat. Biotechnol. 23:1008-1012.
19. Høiby, N., H. Krogh Johansen, C. Moser, Z. Song, O. Ciofu, and A. Kharazmi. 2001. Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. Microbes Infect. 3:23-35.
20. Hoffmann, L. R., D. A. D'Argenio, M. J. MacCoss, Z. Zhang, R. A. Jones, and S. I. Miller. 2005. Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 436:1171-1175.
21. Hutchison, M. L., and J. R. Govan. 1999. Pathogenicity of microbes associated with cystic fibrosis. Microbes Infect. 1:1005-1014.
22. Junker, L. M., and J. Clardy. 2007. High-throughput screens for small-molecule inhibitors of Pseudomonas aeruginosa biofilm development. Antimicrob. Agents Chemother. 51:3582-3590.
23. Kaneko, Y., M. Thoendel, O. Olakanmi, B. E. Britigan, and P. K. Singh. 2007. The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity. J. Clin. Investig. 117:877-888.
24. Köhler, T., L. K. Curty, F. Barja, C. van Delden, J. C. Pechere. 2000. Swarming of Pseudomonas aeruginosa is dependent on cell-to-cell signaling and requires flagella and pili. J. Bacteriol. 182:5990-5996.
25. Linares, J. F., I Gustafsson, F. Baquero, and J. L. Martinez. 2006. Antibiotics as intermicrobial signaling agents instead of weapons. Proc. Natl. Acad. Sci. USA 103:19484-19489.
26. Macfarlane, E. L., A. Kwasnicka, and R. E. W. Hancock. 2000. Role of Pseudomonas aeruginosa PhoP-PhoQ in resistance to antimicrobial cationic peptides and aminoglycosides. Microbiology 146:2543-2554.
27. Manfredi, R., A. Nanetti, M. Ferri, and F. Chiodo. 2000. Pseudomonas spp. complications in patients with HIV disease: an eight-year clinical and microbiological survey. Eur. J. Epidemiol. 16:111-118.
28. 2+ induced gene regulation in Pseudomonas aeruginosa. J. Bacteriol. 188:3995-4006.
29. Müh, U., M. Schuster, R. Heim, A. Singh, E. R. Olson, and E. P. Greenberg. 2006. Novel Pseudomonas aeruginosa quorum-sensing inhibitors identified in an ultra-high-throughput screen. Antimicrob. Agents Chemother. 50:3674-3679.
30. OToole, G. A., L. A. Pratt, P. I. Watnick, D. K. Newman, V. B. Weaver, and R. Kolter. 1999. Genetic approaches to study of biofilms. Methods Enzymol. 310:91-109.
31. Overhage, J., M. Schemionek, J. S. Web, and B. H. A. Rehm. 2005. Expression of the psl operon in Pseudomonas aeruginosa PAO1 biofilms: PslA performs an essential function in biofflm formation. Appl. Environ. Microbiol. 71:4407-4413.
32. Overhage, J., S. Lewenza, A. K. Marr, and R. E. W. Hancock. 2007. Identification of genes involved in swarming motility using a Pseudomonas aeruginosa PAO1 mini-Tn5-lux mutant library. J. Bacteriol. 189:2164-2169.
33. Overhage, J., M. Bains, M. D. Brazas, and R. E. W. Hancock. Swarming of Pseudomonas aeruginosa is a complex adaptation leading to increased production of virulence factors and antibiotic resistance. J. Bacteriol. 190:2671-2679.
34. Pamp, S. J., and T. Tolker-Nielsen. 2007. Multiple roles of biosurfactant in structural biofilm development by Pseudomonas aeruginosa. J. Bacteriol. 189:2531-2539.
35. Picioreanu, C., J. U. Kreft, M. Klausen, J. A. Haagensen, T. Tolker-Nielsen, and S. Molin. 2007. Microbial motility involvement in biofilm structure formation - a 3D modelling study. Water Sci. Technol. 55:337-343.
36. Pitts, B., M. A. Hamilton, N. Zelver, and P. S. Stewart. 2003. A. microtiter-plate screening method for biofilm disinfection and removal. J. Microbiol. Methods 54:269-276.
37. Powers, J. P., and R. E. W. Hancock. 2003. The relationship between peptide structure and antibacterial activity. Peptides 24:1681-1691.
38. Prince, A. S. 2002. Biofilms, antimicrobial resistance, and airway infection. N. Engl. J. Med. 347:1110-1111.
39. Pruitt, B. A., Jr., A. T. McManus, S. H. Kim, and C. W. Goodwin. 1998. Burn wound infections: current status. World J. Surg. 22:135-145.
40. Rajan, S., and L. Saiman. 2002. Pulmonary infections in patients with cystic fibrosis. Semin. Respir. Infect. 17:47-56.
41. Rasmussen, T. B., T. Bjarnsholt, M. E. Skindersoe, M. Hentzer, P. Kristof-fersen, M. Köte, J. Nielsen, L. Eberl, and M. Givskov. 2005. Screening for quorum-sensing inhibitors (OSI) by use of a novel genetic system, the QSI selector. J. Bacteriol. 187:1799-1814.
42. Rasmussen, T. B., M. E. Skindersoe, T. Bjarnsholt, R. K. Phipps. K. B. Christensen, P. O. Jensen, J. B. Andersen, B. Koch, T. O. Larsen, M. Hentzer, L. Eberl, N. Hoiby, and M. Givskov. 2005. Identity and effects of quorum-sensing inhibitors produced by Penicillium species. Microbiology 151:1325-1340.
43. Schlegel, H. G., H. Kaltwasser, and G. Gottschalk. 1961. Ein Submersver-fahren zur Kultur wasserstoffoxidierender Bakterien: Wachstumsphysiologische Untersuchungen. Arch. Mikrobiol. 38:209-222.
44. Schmidtchen. A., I. M. Frick, E. Andersson, H. Tapper, and L. Björck. 2002. Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol. Microbiol. 46:157-168.
45. Schuster, M., C. P. Lostroh, T. Ogi, and E. P. Greenberg. 2003. Identification, timing, and signal specificity of Pseudomonas aeruginosa quorum-controlled genes: a transcriptome analysis. J. Bacteriol. 185:2066-2079.
46. Sieprawska-Lupa, M., P. Mydel, K. Krawczyk, K. Wójcik, M. Puklo, B. Lupa, P. Suder, J. Silberring, M. Reed, J. Pohl, W. Shafer, F. McAleese, T. Foster, J. Travis, and J. Potempa. 2004. Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob. Agents Chemother. 48:4673-4679.
47. Shrout, J. D., D. L. Chopp, C. L. Just, M. Hentzer, M. Givskov, and M. R. Parsek. 2006. The impact of quorum sensing and swarming motility on Pseudomonas aeruginosa biofilm formation is nutritionally conditional. Mol. Microbiol. 62:1264-1277.
48. Singh, P. K., A. L. Scbaefer, M. R. Parsek, T. O. Moninger, M. J. Welsh, and E. P. Greenberg. 2000. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407:762-764.
49. Singh, P. K., M. R. Parsek, E. P. Greenberg, and M. J. Welsh. 2002. A. component of innate immunity prevents bacterial biofilm development. Nature 417:552-555.
50. Stewart, P. S., and J. W. Costerton. 2001. Antibiotic resistance of bacteria in biofilms. Lancet 358:135-138.
51. Stover, C. K., X. Q. Pham, A. L. Erwin, S. D. Mizoguchi, P. Warrener, M. J. Hickey, F. S. L. Brinkman, W. O. Hufnagle, D. J. Kowslik, M. Lagrou, R. L. Garber, L. Goltry, E. Tolentino, S. Westbrock-Wadman, Y. Yuan, U L. Brody. S. N. Coulter, K. R. Folger, A. Kas, K. Larbig, R. Um, K. Smith, D. Spencer, G. K.-S. Wong, Z. Wu, I. T. Paulsen, J. Reizer, M. H. Saier, R. E. W. Hancock, S. Lory, and M. V. Olson. 2000. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406:959-964.
52. Takeyama, K., Y. Kunishima, M. Matsukawa, S. Takahashi, T. Hirose, I. Kobayashi, and T. Tsukamoto. 2002. Multidrug-resistant Pseudomonas aeruginosa isolated from urine of patients with urinary tract infection. J. Infect. Chemother. 8:59-63.
53. Tjabringa, G. S., J. Aarbiou, D. K. Ninaber, J. W. Drijfhout, O. E. Sørensen, N. Borregaard, K. F. Rabe, and P. S. Hiemstra. 2003. The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J. Immunol. 171: 6690-6696.
54. Wagner, V. E., D. Bushnell, L. Passador, A. I. Brooks, and B. H. Iglewski. 2003. Microarray analysis of Pseudomonas aeruginosa quorum-sensing regulons: effects of growth phase and environment. J. Bacteriol. 185:2080-2095.
55. Wu, M., and R. E. W. Hancock. 1999. Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide. Antimicrob. Agents Chemother. 43:1274-1276.
56. Yan, H., and R. E. W. Hancock. 2001. Synergistic interactions between mammalian antimicrobial defense peptides. Antimicrob. Agents Chemother. 45:1558-1560.